In Alzheimer’s disease (AD), elevations of Aβ-42 and tau are observed, and increased Aβ-40 in the plasma has been described as one of the biomarkers for AD. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.